DURANTE MANGONI, Emanuele
 Distribuzione geografica
Continente #
EU - Europa 18.666
NA - Nord America 8.086
AS - Asia 6.984
SA - Sud America 1.338
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 8
Totale 35.199
Nazione #
RU - Federazione Russa 12.198
US - Stati Uniti d'America 7.970
SG - Singapore 2.770
IE - Irlanda 1.940
HK - Hong Kong 1.476
CN - Cina 1.385
BR - Brasile 1.135
UA - Ucraina 1.099
GB - Regno Unito 902
IT - Italia 737
SE - Svezia 489
DE - Germania 418
VN - Vietnam 346
FI - Finlandia 329
KR - Corea 286
TR - Turchia 237
GR - Grecia 192
IN - India 145
FR - Francia 144
JP - Giappone 103
AR - Argentina 87
AT - Austria 75
MX - Messico 46
CA - Canada 42
BD - Bangladesh 40
EC - Ecuador 36
ZA - Sudafrica 32
ID - Indonesia 31
IQ - Iraq 28
BE - Belgio 24
NL - Olanda 24
UZ - Uzbekistan 20
MA - Marocco 18
ES - Italia 17
CO - Colombia 16
EU - Europa 16
KE - Kenya 16
PK - Pakistan 15
PY - Paraguay 15
VE - Venezuela 15
CL - Cile 14
EG - Egitto 12
JO - Giordania 11
PL - Polonia 11
MK - Macedonia 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
AL - Albania 8
JM - Giamaica 8
KZ - Kazakistan 7
LT - Lituania 7
PE - Perù 7
PH - Filippine 7
TN - Tunisia 7
UY - Uruguay 7
AU - Australia 6
BG - Bulgaria 6
BO - Bolivia 6
MY - Malesia 6
NP - Nepal 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
DZ - Algeria 5
HN - Honduras 5
AZ - Azerbaigian 4
BH - Bahrain 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
IL - Israele 4
IR - Iran 4
KG - Kirghizistan 4
LB - Libano 4
TW - Taiwan 4
DK - Danimarca 3
ET - Etiopia 3
KW - Kuwait 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
AM - Armenia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
LY - Libia 1
Totale 35.190
Città #
Moscow 4.279
Dublin 1.936
Jacksonville 1.673
Hong Kong 1.476
Santa Clara 1.146
Singapore 1.030
Chandler 1.011
Princeton 336
Roxbury 274
Seoul 273
Ashburn 249
Hefei 214
Cambridge 207
Boardman 188
Woodbridge 171
Beijing 144
New York 139
Ann Arbor 135
Medford 134
Dallas 132
The Dalles 130
Wilmington 124
Ho Chi Minh City 116
Bengaluru 97
Mountain View 85
Nuremberg 85
São Paulo 85
Des Moines 66
Hanoi 66
San Mateo 63
Naples 56
Nanjing 51
Munich 46
Jinan 40
Lappeenranta 39
Belo Horizonte 34
Marano Di Napoli 32
Rio de Janeiro 32
Los Angeles 30
Vienna 29
Düsseldorf 28
Norwalk 26
Brussels 24
Changsha 22
Milan 22
Shenyang 22
Guangzhou 21
Falkenstein 20
Houston 19
Bremen 18
Helsinki 18
Porto Alegre 18
Brasília 17
Haiphong 17
Nanchang 17
Tashkent 17
Tianjin 17
Toronto 17
Brooklyn 16
Da Nang 16
Washington 16
Dhaka 15
Kunming 15
Salvador 15
Curitiba 14
Nairobi 14
San Francisco 14
Taiyuan 14
Venice 14
Zhengzhou 14
Bologna 13
London 13
Quito 13
Rome 13
Shanghai 13
Boston 12
Guayaquil 12
Hebei 12
Johannesburg 12
Amman 11
Campinas 11
Caserta 11
Chicago 11
Hangzhou 11
Ningbo 11
Ninh Bình 11
Ribeirão Preto 11
Seattle 11
Viterbo 11
Casablanca 10
Guadalupe 10
Joinville 10
Napoli 10
Amsterdam 9
Atlanta 9
Baghdad 9
Cape Town 9
Caxias do Sul 9
Council Bluffs 9
Franca 9
Totale 17.316
Nome #
Endocardite infettiva (EI) nei tossicodipendenti ( IVDU): prevalenza del coinvolgimento del cuore sinistro e cambiamenti del profilo microbiologico 246
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 175
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 157
Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis 153
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 149
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review 149
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 147
Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections 147
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies 138
A case of coagulopathy of unclear definition 138
A case of destructive infective endocarditis 138
20210 G/A prothrombin gene mutation in patients with ischemic heart disease 136
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. 135
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 135
Yellow nail syndrome as a cause of unexplained edema 134
Adefovir treatment for chronic hepatitis B in heart transplant recipients. 133
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 131
Endocardite Infettiva da Streptococcus bovis: risultati dello Studio Endocarditi Italiano (SEI) 131
Clinical efficacy and safety of cefiderocol for resistant gram-negative infections: a real-life, single center experience 130
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 130
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study 130
Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital 129
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes 127
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals 126
The value of open-source clinical science in pandemic response: lessons from ISARIC 125
Clinical Characteristics and Outcome of MDR/XDR Bacterial Infections in a Neuromuscular Semi-Intensive/Sub-Intensive Care Unit 124
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infection diseases specialists practicing in large hospitals 124
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases 123
Clinical significance and prognostic value of hemostasis parameters in 337 patients with acute infective endocarditis 123
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19 122
Caratteristiche attuali dell'endocardite infettiva in Italia: risultati dello Studio Endocarditi Italiano (SEI) 122
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 120
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 120
Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis 120
Right diaphragm paralysis following cardiac radiofrequency catheter ablation for inappropriate sinus tachycardia 119
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 119
A European first: Successful heart transplant in a human immunodeficiency virus-positive recipient 119
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 119
Epatopatia cronica ed endocardite infettiva: risultati dello studio endocardite italiano (SEI) 119
Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure 119
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 118
. Iperomocisteinemia in pazienti con cardiomiopatia dilatativa: relazione con i parametri di funzione cardiaca e ruolo dei polimorfismi genici predisponenti 117
Associating enterococcal endocarditis and colorectal neoplasia: is colonoscopy mandatory? – Authors’ reply 117
Risk factors and outcome of multidrug-resistant infections after heart transplant: A contemporary single center experience 117
Emerging Concepts on Infection of Novel Cardiac Implantable Devices 116
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry 116
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 116
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 116
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion 115
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 115
Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. 114
Effects of growth hormone therapy in Becker patients with dilated cardiomyopathy 114
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 114
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 114
Does this patient have COVID-19? A practical guide for the internist 114
Viral Hepatitis C 114
Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients 114
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 113
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 113
Pharmacokinetic parameters of CAZ-AVI in the normal lung and in models of pneumonia: lessons for treatment optimization in critical care 112
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 112
Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence 112
Growth hormone deficiency in patients with Duchenne/Becker muscular dystrophy: association with dilated cardiomyopathy 111
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 110
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review 109
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment 109
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. 108
Infective endocarditis on cardiac rhythm management devices: preliminary study on the possible pathogenic role of inherited thrombophilias 108
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19 108
Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C 107
Short-term effective bactericidal treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 107
Utilità dell'esame colturale ed isto-patologico della valvola nell'endocardite infettiva 107
Monkeypox infection: An update for the practicing physician 107
Evidence-Based Treatment of Pseudomonas aeruginosa Infections: A Critical Reappraisal 106
Risk factors for "major" embolic events in hospitalized patients with infective endocarditis 106
Rhodococcus equi as a cause of Infective Endocarditis: description of 2 clinical cases 106
Efficacia e sicurezza della combinazione colistina-rifampicina in confronto con la colistina in monoterapia nelle infezioni gravi da Acinetobacter baumannii MDR: risultati preliminari 106
Factor V Leiden and glycoprotein IIIa PlA2 polymorphism in coronary thrombosis 106
Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies 105
Ruolo dell’asse GH/IGF-1 nella fisiopatologia e nella terapia cardiovascolare: lezioni da studi sull’animale 105
Mild chronic hepatitis C with steatosis: Which treatment? 105
Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant 104
Management of carbapenem resistant Enterobacteriaceae infections 104
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 103
Comunicazione orale: Association of plasma homocysteine levels with infective endocarditis. 103
Factors affecting hospital mortality in critically ill patients with multi-drug resistant Acinetobacter baumannii 103
Correlation of serum HBeAg levels and double A1762T/G1764A HBV core promoter mutation with response to interferon in patients with chronic hepatitis B 103
Growth hormone evaluation in patients with dystrophinopathic muscular dystrophy and dilated cardiomyopathy 103
Drugs and liver injury: a not to be overlooked binomial in COVID-19 103
Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts 102
Heart failure in infective endocarditis: a report from the multicenter, prospective, observational Study on Endocarditis in Italy (SEI) 102
Oral presentation: Treatment of Duchenne dystrophy: results of 7 years cloprednol oral administration 102
Long-Term Outcome of Infective Endocarditis Involving Cardiac Implantable Electronic Devices: Impact of Comorbidities and Lead Extraction 101
Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview 101
Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients 101
Unusually high rate of hepatic comorbidity with Streptococcus bovis endocarditis: trend or coincidence? 101
Successful control of bleeding with recombinant activated factor VII (FVIIa) after cardiac re-transplantation in a patient on aggressive antiplatelet treatment 101
Features of infective endocarditis in persons on chronic hemodialysis. Results from the prospective, observational SEI study (Italian Study on Endocarditis) 101
Report on 509 defined cases of infectious endocarditis of the multicentric italian study (SEI) 101
Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors 100
Totale 11.879
Categoria #
all - tutte 124.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.415 0 0 0 0 0 8 310 271 23 368 292 143
2021/20221.878 71 15 9 31 686 13 29 58 62 87 151 666
2022/20233.795 368 57 22 331 381 327 25 260 1.814 36 83 91
2023/20241.621 144 45 67 90 595 136 54 74 10 20 156 230
2024/20255.351 14 55 54 159 783 701 554 569 610 1.191 403 258
2025/202617.159 699 881 1.032 1.145 1.678 11.724 0 0 0 0 0 0
Totale 35.689